Navigation Links
More people surviving cancer in Northern Ireland
Date:2/28/2012

Despite the rising incidence of cancer in Northern Ireland, the number of people surviving the disease in the country is increasing significantly year on year.

Each year there are between 50-60 men and women who survive the deadly effects of cancer who previously would have died.

The survival rates in Northern Ireland for cancers including breast and colorectal are among the best in the UK, and its patients are benefiting from improved treatment outcomes by up to four per cent better than those for England and Wales.

The figures have been revealed as Queen's University Belfast accepted a Diamond Jubilee Queen's Anniversary Prize at Buckingham Palace, in recognition of its leadership of the Northern Ireland Comprehensive Cancer Services (CCS) programme.

The CCS programme has been credited with driving forward the improvements in cancer survival in Northern Ireland. It is a collaboration led by Queen's University in partnership with the Department of Health and the five Northern Ireland Health Trusts with support from the medical research industry.

The programme has resulted in the reorganisation of cancer services across Northern Ireland, and investment of more than 200 million in infrastructure and personnel for treatment and research by the University and the health service.

The CCS programme was also recently described by the distinguished medical journal, The Oncologist, as 'life-extending research that is emblematic of the way cancer medicine should be conducted in the 21st century.'

Accepting the prize, Professor Patrick Johnston, Dean of the School of Medicine, Dentistry and Biomedical Sciences, said: "Despite the rising incidence rates of cancer, between 1993 and 2009, the number of men dying from cancer has gone down by 1.3 per cent and the number of women by 0.9 per cent. Some of our survivors are currently alive and well a significant number of years after the kind of cancer that not so long ago would have taken them from us.

"Cancer no longer needs to be seen as an inevitable death sentence. In many instances it can now be viewed instead as a chronic disease."

He added: "This award underpins our reputation as a global centre of excellence for cancer care. To receive it is a singular honour, not just for Queen's but for the whole of Northern Ireland and in particular all the fundraisers, the Department of Health, Social Services and Public Safety, the five Northern Ireland Health and Social Care Trusts and our supporters from the national and international medical research industry.

"Our strength lies in a multidisciplinary approach teams of scientists and clinicians working together across academic and NHS boundaries on behalf of cancer patients and their families."

Queen's Vice Chancellor Professor Sir Peter Gregson said: "Queen's is committed to high quality translational research. We are seeing innovations which are providing life-saving and life-enhancing results, reflecting our drive to become a global force in the fight against cancer."

The pillars of the CCS programme are the Clinical Cancer Centre at Belfast City Hospital, the Centre for Cancer Research and Cell Biology, the Cancer Research Programme at Queen's and the University's Northern Ireland Cancer Registry which provides vital information about research and outcomes.


'/>"/>

Contact: Lisa McElroy
lisa.mcelroy@qub.ac.uk
44-289-097-5384
Queen's University Belfast
Source:Eurekalert

Related biology news :

1. Indigenous peoples at forefront of climate change offer lessons on plant biodiversity
2. Potatoes lower blood pressure in people with obesity and hypertension without increasing weight
3. Gut microbe networks differ from norm in obese people, systems biology approach reveals
4. Pythons and people take turns as predators and prey
5. People matter in climate change models
6. Peter Went Wins ID Peoples Trail Blazer Awards
7. 7 billion people are not the issue - human development is what counts
8. Can indigenous peoples be relied on to gather reliable environmental data?
9. Study finds promising drug treatment for improving language, social function in people with autism
10. Religion and ecology among Chinas Blang people
11. Gene defect that predisposes people to leukemia discovered
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel ... came to the DERMALOG stand together with the Japanese Prime Minster Shinzo ... At the largest German biometrics company the two government leaders could see ... as well as DERMALOG´s multi-biometrics system.   Continue ... ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... OF PRUSSIA, Pa. , March 29, 2017 /PRNewswire/ ... to care, which is why CSL Behring awards Local ... work of rare disease patient groups. These groups tackle ... voices are heard on Capitol Hill and in statehouses ... funding cycle, the community-based grant was awarded to New ...
(Date:3/29/2017)... Germany , March 29, 2017 QIAGEN N.V. ... QIA) today announced the U.S. launch of its ipsogen ® ... by the U.S. Food and Drug Administration as a qualitative in vitro diagnostic ... from EDTA whole blood.* ... JAK2 assay is processed on QIAGEN,s Rotor-Gene ® Q MDx system, ...
(Date:3/29/2017)... SPRINGS, CO , March 29, 2017 /PRNewswire/ - Last year,s ... support kratom are not the only efforts active to generate awareness ... substitute opiate based pharmaceutical drugs in the healthcare market place. ... Earlier this month ... based developer and distributor of pharmaceutical and nutritional products, announced its ...
(Date:3/29/2017)... N.J. and PETACH TIKVAH, ...  BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), ... technologies for neurodegenerative diseases, announced financial results ... "2016 was a highly successful ... important achievements and significant progress made on ...
Breaking Biology Technology: